Primary central nervous system small lymphocytic lymphoma in the bilateral ventricles: two case reports

• Published in: BMC neurology 2019-08, Vol.19 (1), p.200-200, Article 200
• Main Authors: Guo, Rongjing, Zhang, Xiaolong, Niu, Chunxiao, Xi, Yibin, Yin, Hong, Lin, Hong, Chang, Ting
• Format: Article
• Language: English
• Subjects: Bilateral ventricular neoplasm; Care and treatment; Case Report; Central nervous system; Health aspects; Lymphomas; Medical research; Medicine, Experimental; Non-Hodgkin lymphoma; Radiology; Radiology, Medical; Small lymphocytic lymphoma
• ISSN: 1471-2377; 1471-2377
• DOI: 10.1186/s12883-019-1430-3

Primary central nervous system (CNS) small lymphocytic lymphoma (SLL), as a type of low-grade lymphoma, is extremely rare. The diagnosis of CNS SLL is challenging due to its variable clinical and radiological features, which may overlap with those of diffuse large B-cell lymphoma (DLBCL). Primary CNS SLL differs from DLBCL in that it has an indolent clinical course and a good prognosis. Thus, it is important to distinguish SLL from DLBCL. By reviewing the literature, only two cases of low-grade SLL, primarily located in the CNS and involving the brain parenchyma and dura, have been reported. To our knowledge, primary CNS SLL in the bilateral ventricles has never been reported. Interestingly, the two cases in our report are identical in terms of the clinical presentations, magnetic resonance imaging (MRI) features, pathological results and prognoses. Both patients presented with headaches. MRI suggested solid lesions located in the bilateral ventricles that were isointense on T1-weighted images and hypointense on T2-weighted images. After the injection of contrast agent (gadolinium, Gd), the intraventricular lesions were homogeneously enhanced and hyperperfused. CSF cytology revealed malignant cells. Brain biopsy revealed diffuse proliferation of small lymphocytes with positive labelling of B-cell immunomarkers. The primary origin in the CNS was confirmed with no evidence of systemic lymphoma. Two patients were given high doses of methotrexate-based chemotherapy and were free from symptoms and progression for more than 1-year of follow-up. The presence of homogeneously enhanced intraventricular MRI lesions should raise the suspicion of primary CNS SLL.